Morphometric aspects of precancerous laryngeal hyperplastic lesions


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Hyperplastic processes in the larynx currently remain a very common pathology of the ENT organs, accounting for 8.4% of their total number. The great importance of this problem is attributable to the fact that hyperplastic processes in the larynx are prone to malignancy with further development of laryngeal cancer, which accounts for 69-70% among tumors of the upper respiratory tract. It is not always possible to differentiate a benign pathological process by cytological preparations. The use of cellular morphometry makes it possible to objectify the cytological examination and indentify the parameters that are significant for differential diagnosis. Objective. Improvement of the diagnosis of laryngeal pathology by morphometry of nuclear polymorphism of epithelial cells of vocal cords. Methods. The objects of the study were cytological preparations of biopsy material from visually altered areas of the laryngeal mucosa of 30 patients with chronic hyperplastic laryngitis and papillomatosis/papilloma. Results. Significant differences were found between precancerous conditions of the epithelium and squamous cell carcinoma that occurs against the background of papillary hyperplasia or papillomatosis. The most informative were the core area index and the shape factor. Conclusion. Cellular morphometry made it possible to objectify the cytological examination and identify criteria that are significant for the differential diagnosis of precancerous and cancerous changes in the epithelium of the vocal cords. The quantitative indicators obtained can be used as an additional objective differential diagnostic criterion for distinguishing between precancerous (dysplastic) and cancerous changes in the epithelium of the vocal cords.

Full Text

Restricted Access

About the authors

A. U Gekhaev

North Ossetian State Medical Academy; IMed Oncology Center

Email: gekhaev-alikhan@mail.ru
Vladikavkaz, Russia

F. S Isakova

Medical Institute of the Chechen State University

Vladikavkaz, Russia

E. T Gappoeva

North Ossetian State Medical Academy

Vladikavkaz, Russia

References

  1. Литвиненко И.В., Ростовцев М.В., Литвиненко Ю.М. Возможности МСКТ в дифференциальной диагностике гиперпластических процессов и рака гортани. Сибирский онкологический журнал. 2011;2:45-6.
  2. Нажмудинов И.И., Гаращенко Т.И., Серебрякова И.Ю. и др. Современные аспекты диагностики и хирургического лечения гиперпластических процессов гортани. Consilium Medicum. 2017;19(11):29-33.
  3. Tuljapure A.N., Deshmukh S., Jain S.K.T., et al. Clinicopathological study of benign lesions of larynx. J Evolut Med Dent Sci. 2018;7(20):2468- 74.
  4. Никита Е.И.,Гавриленко А.С.,Лой В.Ю.,Хоров О.Г. Клинико морфологические аспекты гиперпластических изменений гортани. В сборнике: Актуальные проблемы медицины. Сборник материалов итоговой научно-практической конференции. Отв. редактор - В.А. Снежицкий. 2020. С. 501-4
  5. Кулагин Р.Н. Особенности дифференцировки и пролиферации клеток плоскоклеточного рака гортани. Казанский медицинский журнал. 2011;92(6):851-54
  6. Bobdey S., Jain A. Balasubramanium G. Epidemiological review of laryngeal cancer: An Indian Perspect Indian J Med. Paediatr Oncol. 2015;36(3):154-60. doi: 10.4103/0971-5851.166721.
  7. Kinnari T.J. The role of biofilm in chronic laryngitis and in head and neck cancer. Otolaryngol. Head Neck Surg. 2015;23(6):448-53. Doi: 10.1097/ M00.0000000000000200.
  8. Koirala K. Epidemiological Study of Laryngeal Carcinoma in Western Nepal. Asian Pac J Cancer Prev. 2015;16(15):6541-44. Doi: 10.7314/ apjcp.2015.16.15.6541.
  9. Lim S. Sau P., Cooper L., et al. Laryngeal biopsies: are we doing more, and why? Laryngol Otol. 2016;130(1):100-3. Doi: 10.1017/ S0022215115002972.
  10. Andratschke M., Schmitz S., Hagedorn H., et al. Cytological and Immunocytological Monitoring of Oropharyngeal Dysplasia and Squamous Cell Carcinomas. Anticancer Res. 2015;35(12): 6517-20.
  11. Dai L, Liu T., Zhou X., et al. Expression and significance of phosphated signal transducer and activator of transcription 3 and p53 protein in laryngeal squamous cell carcinoma. Hou Tou Jing Wai Ke Za Zhi. 2013;27(18): 991-94.
  12. Hu Y, Liu H. Histopathological variability and the prognosis of laryngeal premalignant lesions. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;(12):979-85.
  13. Johnson K., Derkay С. Palliative aspects of recurrent respiratory papillomatosis. Otolaryngol. Clin. North Am. 2009;42(l):57-70. Doi: 10.1016/]. otc.2008.09.007.
  14. Karatayli-Ozgursoy S. Laryngeal dysplasia, demographics, and treatment: a single-institution, 20-year review. JAMA. Otolaryngol. Head Neck Surg. 2015;141(4):313-18. Doi: 10.1001/ jamaoto.2014.3736.
  15. Yu P, Qu G., Yang J., et al. A retrospective study on the diagnosis and treatment of vocal folds white lesions. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015;50(12):978-82.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies